Jean Boyer

12.6k citations

140 papers · 7.5k indexed · 2 hit papers · h-index 46

Impact in

Virology top 0.2%
- HIV Research and Treatment
Immunology top 0.2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in

Virology 75
- HIV Research and Treatment 74
Immunology 94
- Immunotherapy and Immune Responses 58
- Immune Cell Function and Interaction 45
- T-cell and B-cell Immunology 26

Co-authors: David B. Weiner Michael A. Chattergoon Kenneth E. Ugen Mark L. Bagarazzi Kesen Dang Michael G. Agadjanyan Richard B. Ciccarelli William V. Williams
Journals: Vaccine (18 papers)The Journal of Infectious Diseases (7 papers)Virology (6 papers)DNA and Cell Biology (6 papers)Journal of Medical Primatology (6 papers)
Partner nations: United States Canada Japan

In The Last Decade

Jean Boyer

136 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response 1998 · 503 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1998 The Journal of Infectious Diseases
1993 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Jean Boyer

Since Specialization

Citations

This map shows the geographic impact of Jean Boyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Boyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Boyer more than expected).

Fields of papers citing papers by Jean Boyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Boyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Boyer. The network helps show where Jean Boyer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jean Boyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jean Boyer Line = papers co-authored together Jean Boyer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Clinical Cancer Research ·Charu Aggarwal, Nabil F. Saba, Alain P. Algazi, Ammar Sukari, Tanguy Y. Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo Bonomi, Jean Boyer, Mark T. Esser, Lily Cheng, Sonia Agrawal, Emily C. Jennings, Nicholas M. Durham, berhanu wubela, P Gou, Diane Owen, Patrick G. Donnelley, Larissa Morgana Ferreira Scopel, Rakesh Kumar	2022	26
2	Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection Cancer Prevention Research ·Jeffrey M. Jacobson, David M. Zahrieh, Carrie Strand, Marcia Cruz‐Correa, Surakit Pungpapong, Lewis R. Roberts, Sumithra J. Mandrekar, Luz M. Rodriguez, Jean Boyer, Idania Marrero, Kimberly A. Kraynyak, Matthew P. Morrow, Albert J. Sylvester, Jan M. Pawlicki, Elisabeth Gillespie, Francisco Menino dos SANTOS NETO, Ellen Richmond, Asad Umar, David B. Weiner, Paul J. Limburg, (unknown)	2022	11
3	916MO Safety and efficacy of MEDI0457 plus durvalumab in patients (pts) with human papillomavirus-associated recurrent/metastatic head and neck squamous cell carcinoma (HPV+ R/M HNSCC) Annals of Oncology ·Charu Aggarwal, Nabil F. Saba, Alain P. Algazi, Ammar Sukari, Tanguy Y. Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo Bonomi, Jean Boyer, Nicholas M. Durham, Rakesh Kumar, Kevin Laubscher, Yuko Hatakeyama, Patrick G. Donnelley, 邓小梅	2020	16
4	Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy Clinical Cancer Research ·Matthew P. Morrow, Kimberly A. Kraynyak, Albert J. Sylvester, Michael Dallas, Dawson Knoblock, Jean Boyer, Jian Yan, Russell Vang, Amir Sada Khan, Laurent Humeau, Niranjan Y. Sardesai, J. Joseph Kim, Stanley A. Plotkin, David B. Weiner, Cornelia L. Trimble, Mark L. Bagarazzi	2017	34
5	Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease Mucosal Immunology ·Thangaraj Karuppuchamy, Minyue Wang, Pedro J. Gonzalez‐Cabrera, Gor Sarkisyan, M.R. Martín de Cabo, Jean Boyer, Giorgos Bamias, Peter Jedlička, Marisol Veny, Daniel J. Clark, Robert Peach, Fiona L. Scott, Hugh Rosen, Jesús Rivera–Nieves	2016	98
6	Synthetic Consensus HIV-1 DNA Induces Potent Cellular Immune Responses and Synthesis of Granzyme B, Perforin in HIV Infected Individuals Molecular Therapy ·Matthew P. Morrow, Pablo Tebas, Jian Yan, Jorge Flecha, S. A. Vazartsev, C. Liling, Malissa Diehl, Divya Shah, Amir Sada Khan, Jessica Lee, Jean Boyer, J Joseph Kim, Niranjan Y. Sardesai, David B. Weiner, Mark L. Bagarazzi	2014	14
7	Effects of behavioral stress reduction Transcendental Meditation intervention in persons with HIV AIDS Care ·Sumedha Chhatre, David S. Metzger, Ian Frank, Jean Boyer, Edward H. Thompson, Sanford Nidich, Luis J. Montaner, Ravishankar Jayadevappa	2013	39
8	Immunotherapy Against HPV16/18 Generates Potent T _H 1 and Cytotoxic Cellular Immune Responses Science Translational Medicine ·Mark L. Bagarazzi, Jian Yan, Matthew P. Morrow, Xuefei Shen, Raphaëlle Parker, Jessica C. Lee, Mary Giffear, Panyupa Pankhong, Amir Sada Khan, Kate E. Broderick, Christine Knott, Feng Lin, Jean Boyer, Ruxandra Draghia‐Akli, E LIBSON, J. Joseph Kim, David B. Weiner, Niranjan Y. Sardesai	2012	229
9	Adoptive Transfer of Autologous T Cells Improves T-cell Repertoire Diversity and Long-term B-cell Function in Pediatric Patients with Neuroblastoma Clinical Cancer Research ·Stephan A. Grupp, Eline T. Luning Prak, Jean Boyer, Kenyetta R. McDonald, Suzanne Shusterman, Awadhesh Kumar, Colleen Callahan, Abbas F. Jawad, Bruce L. Levine, Carl H. June, Kathleen E. Sullivan	2012	31
10	Plasmodium inui Infection Reduces the Efficacy of a Simian Immunodeficiency Virus DNA Vaccine in a Rhesus Macaque Model Through Alteration of the Vaccine-Induced Immune Response The Journal of Infectious Diseases ·Jiming Yin, Maryanne Vahey, Érica de Sá Earp Siqueira, Mark G. Lewis, 姚贤, Marie H. Schultz, Jack Greenhouse, A Riedel, Amir Sada Khan, Niranjan Y. Sardesai, Jason Weiss, Jack Komisar, Jean Boyer	2012	7
11	High antibody and cellular responses induced to HIV-1 clade C envelope following DNA vaccines delivered by electroporation Vaccine ·Davide Chersola, Anlan Dai, 胡景琨, 姚贤, Michele A. Kutzler, Jian Yan, Mark G. Lewis, Amir Sada Khan, Niranjan Y. Sardesai, D Montefiore, Ruth M. Ruprecht, David B. Weiner, Jean Boyer	2011	28
12	CD8+ Cell Depletion of SHIV89.6P-Infected Macaques Induces CD4+ T Cell Proliferation that Contributes to Increased Viral Loads The Journal of Immunology ·Yvonne M. Mueller, Duc H., Jean Boyer, (unknown), Joseph J. Mattapallil, Mark G. Lewis, David B. Weiner, Peter D. Katsikis	2009	22
13	Immunogenicity Testing of a Novel Engineered HIV-1 Envelope Gp140 DNA Vaccine Construct DNA and Cell Biology ·Sanjeev Kumar, Jian Yan, Kar Muthumani, Mathura P. Ramanathan, Jesús Viera, George N. Pavlakis, Barbara K. Felber, Maninder K. Sidhu, Jean Boyer, David B. Weiner	2006	18
14	Coimmunization with an Optimized IL-15 Plasmid Results in Enhanced Function and Longevity of CD8 T Cells That Are Partially Independent of CD4 T Cell Help The Journal of Immunology ·Michele A. Kutzler, Tara M. Robinson, Michael A. Chattergoon, Daniel Choo, Andrew Y. Choo, Sunjoyo Sunjoyo, Mathura P. Ramanathan, Rose Parkinson, Sagar B. Kudchodkar, Yutaka Tamura, Maninder K. Sidhu, Vidia Roopchand, Chang Yu Jin, George N. Pavlakis, Barbara K. Felber, Thomas A. Waldmann, Jean Boyer, David B. Weiner	2005	152
15	Priming with Plasmid DNAs Expressing Interleukin-12 and Simian Immunodeficiency Virus Gag Enhances the Immunogenicity and Efficacy of an Experimental AIDS Vaccine Based on Recombinant Vesicular Stomatitis Virus AIDS Research and Human Retroviruses ·Michael A. Egan, Siew Yen Chong, Shakuntala Megati, David C. Montefiori, Nina F. Rose, Jean Boyer, Maninder K. Sidhu, Jorge Quiroz, Margherita Rosati, Eva B. Schadeck, George N. Pavlakis, David B. Weiner, John K. Rose, Zimra R. Israel, Stephen A. Udem, John H. Eldridge	2005	56
16	Parasitic Infection and the Polarized Th2 Immune Response Can Alter a Vaccine-Induced Immune Response DNA and Cell Biology ·Tara M. Robinson, Robin Nelson, Jean Boyer	2003	9
17	Plasmid Immunization Primes Unique DTH Responses to HIV-1 _MN Envelope Epitopes as Compared to Recombinant Protein Vaccination PubMed ·Michael A. Chattergoon, L. MUELLER‐KUHRT, Tara M. Robinson, Zhiming Yuan, Jean Boyer, David B. Weiner	2002	1
18	Protection from Immunodeficiency Virus Challenges in Rhesus Macaques by Multicomponent DNA Immunization Virology ·S. M. von Bary, Joo-Sung Yang, Liesl Nottingham, Victor Manuel Garcia, Ari Sukma Kinanti, Kelledy Manson, Michael S. Wyand, Jean Boyer, Kenneth E. Ugen, David B. Weiner	2001	32
19	DNA Vaccination as Anti—Human Immunodeficiency Virus Immunotherapy in Infected Chimpanzees The Journal of Infectious Diseases ·Jean Boyer, Kenneth E. Ugen, Michael A. Chattergoon, Bin Wang, J. Brouardel, Michael G. Agadjanyan, Mark L. Bagarazzi, Ali Javadian, Richard A. Carrano, Leslie R. Coney, William V. Williams, David B. Weiner	1997	40
20	Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1. Journal of Clinical Investigation ·Kenneth E. Ugen, James J. Goedert, Jean Boyer, Yosef Refaeli, Ian Frank, William V. Williams, Gustafson Eric, Sheldon H. Landesman, J. Manuel Currea Urcua, A. Rubinstein	1992	70

About Jean Boyer

Jean Boyer is a scholar working on Virology, Immunology, Epidemiology, Infectious Diseases and Otorhinolaryngology, having authored 140 papers that have together received 7.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (74 papers), Immunotherapy and Immune Responses (58 papers), Immune Cell Function and Interaction (45 papers), T-cell and B-cell Immunology (26 papers), vaccines and immunoinformatics approaches (18 papers), Herpesvirus Infections and Treatments (14 papers), RNA Interference and Gene Delivery (12 papers) and Cervical Cancer and HPV Research (10 papers). The work is most often cited by research in Virology (2.2k citations), Immunology (4.7k citations), Infectious Diseases (1.3k citations), Epidemiology (2.0k citations) and Biotechnology (399 citations). Jean Boyer has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include David B. Weiner, Michael A. Chattergoon, Kenneth E. Ugen, Mark L. Bagarazzi, Kesen Dang, Michael G. Agadjanyan, Richard B. Ciccarelli, William V. Williams, B Wang and Leslie R. Coney. Their work appears in journals such as Vaccine, The Journal of Infectious Diseases, Virology, DNA and Cell Biology and Journal of Medical Primatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact